An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

In this webinar, a detailed discussion is done on the front-line management of ALK-positive Lung Cancer.

Speakers : Dr Vijay Agarwal ,Dr. Ananth Pai ,Dr. Sai Vivek ,Dr. Harish P

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

In this webinar, a detailed discussion is done on the front-line management of ALK-positive Lung Cancer.

Speakers : Dr. Harish P ,Dr. Sai Vivek ,Dr. Ananth Pai ,Dr Vijay Agarwal

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

In this webinar, a detailed discussion is done on the front-line management of ALK-positive Lung Cancer.

Speakers : Dr. Vijay Agarwal ,Dr. Ananth Pai ,Dr. Sai Vivek ,Dr. Harish P

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

In this webinar, a detailed discussion is done on the front-line management of ALK-positive Lung Cancer.

Speakers : Dr. Harish P ,Dr. Sai Vivek ,Dr. Ananth Pai ,Dr Vijay Agarwal

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

In this webinar, a detailed discussion is done on the front-line management of ALK-positive Lung Cancer.

Speakers : Dr Vijay Agarwal ,Dr. Ananth Pai ,Dr. Sai Vivek ,Dr. Harish P

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

Explore the impact of CDK4/6 inhibition in HR+/HER2- metastatic breast cancer, drawing insights from the pivotal PALOMA-2 study presented by Dr. Bhavna Parikh.

Speakers : Dr Bhavna Parikh

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

Discover the comprehensive impact of CDK4/6 inhibition in HR+/HER2- metastatic breast cancer, with key insights from the PALOMA-2 study presented by Dr. Bhavna Parikh.

Speakers : Dr Bhavna Parikh

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

Explore the multifaceted advantages of CDK4/6 inhibitors in HR+/HER2- breast cancer, based on the PALOMA-2 study, in this insightful session with Dr. Bhavna Parikh.

Speakers : Dr Bhavna Parikh

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

A detailed discussion on the benefits of using CDK4/6 inhibitors in HR+/ HER2-aBC in clinical trials.

Speakers : Dr. Bhavna Parikh

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

The webinar gives insights into the role of pazopanib in managing renal cell carcinoma.

Speakers : Dr. Yogesh Kumar ,Dr. Pankaj Goyal ,Dr. Jatin Sarin ,Dr. Ankur Punia


Recommended News For You

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

Using AI, one can find cancer risk factors.

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

Discovery of estrogen receptor 'switches' may aid breast cancer treatment

Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.

NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.

Recommended Articles For You

Advancements in Cancer Treatment and Survival Outcomes for Acute Myeloid Leukemia 

What is Hemorrhagic Cystitis and How to Manage its Symptoms 

Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging 

What is Mullerian and How Does it Affect Your Health 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.

2.

A small rise in cancer was observed following the 1986 Chernobyl accident.

3.

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.

4.

The hidden costs of cancer for young survivors are derailing their financial futures

5.

Report reveals lung cancer is the leading cause of cancer deaths in Florida

1.

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies

2.

Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis

3.

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology

4.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

5.

What You Need To Know About Secondary Polycythemia: Treatment & Symptoms

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

4.

Understanding the causes of anemia in adults beyond nutritional deficiencies

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot